Trial Profile
Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Otitis media; Pneumococcal infections
- Focus Therapeutic Use
- 08 Dec 2015 New trial record